U.S. Senator Tammy Baldwin (D-WI) joined a group of her colleagues in introducing the Capping Prescription Costs Act, ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Older Americans have ways to protect against high out-of-pocket health care costs, but it’s important to understand the trade ...
Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...
Two Trump administration nominees with long track records of challenging the medical and public health establishments have ...
Voluntary action indicated (VAI) is suggested when violations are found, but the problems do not justify further regulatory ...
Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...
The bad economics of import taxes was succinctly summed up by Senator Rand Paul (R-KY), one of the few Republicans to criticize Trump’s tariffs: “Tariffs are simply taxes. Conservatives once united ...
The Department of Agriculture warned egg prices may increase more than 20% this year, after December saw a year-over-year ...
Opinion
20hon MSNOpinion
Senate Bill 14 in the ongoing Kentucky legislative session relates to the federal 340B Drug Pricing Program. This program enables hospitals and other health care providers who serve a disproportionate ...
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.
In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results